SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 48 filers reported holding SATSUMA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | -100.0% | 63 | -99.3% | 0.00% | – |
| Q1 2021 | $51,000 | +27.5% | 8,700 | 0.0% | 0.00% | – |
| Q4 2020 | $40,000 | +17.6% | 8,700 | 0.0% | 0.00% | – |
| Q3 2020 | $34,000 | -86.4% | 8,700 | 0.0% | 0.00% | – |
| Q2 2020 | $250,000 | +111.9% | 8,700 | +58.2% | 0.00% | – |
| Q1 2020 | $118,000 | +9.3% | 5,500 | 0.0% | 0.00% | – |
| Q4 2019 | $108,000 | – | 5,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 3,118,761 | $14,533,000 | 3.83% |
| Ghost Tree Capital, LLC | 904,225 | $4,214,000 | 1.23% |
| RA Capital Management | 5,914,252 | $27,560,000 | 0.38% |
| Vivo Capital, LLC | 1,232,394 | $5,743,000 | 0.26% |
| Nan Fung Group Holdings Ltd | 142,900 | $666,000 | 0.21% |
| Ikarian Capital, LLC | 629,384 | $2,934,000 | 0.21% |
| NEA Management Company, LLC | 3,142,958 | $14,646,000 | 0.17% |
| SAMLYN CAPITAL, LLC | 1,716,067 | $7,998,000 | 0.11% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,885,939 | $8,788,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 90,665 | $422,000 | 0.04% |